Revenue (Annual) Chart

Historical Revenue (Annual) Data

View and export this data back to 1992. Start Trial.
Date Value
December 31, 2025 17.46B
December 31, 2024 16.59B
December 31, 2023 15.81B
December 31, 2022 14.86B
December 31, 2021 15.86B
December 31, 2020 16.78B
December 31, 2019 16.93B
December 31, 2018 18.21B
December 31, 2017 22.56B
December 31, 2016 21.98B
December 31, 2015 19.62B
December 31, 2014 20.22B
December 31, 2013 20.37B
December 31, 2012 20.31B
December 31, 2011 18.24B
December 31, 2010 16.12B
December 31, 2009 13.91B
Date Value
December 31, 2008 11.13B
December 31, 2007 9.411B
December 31, 2006 8.410B
December 31, 2005 5.249B
December 31, 2004 4.798B
December 31, 2003 3.278B
December 31, 2002 2.521B
December 31, 2001 2.072B
December 31, 2000 1.753B
December 31, 1999 5.311B
December 31, 1998 4.242B
December 31, 1997 1.117B
December 31, 1996 953.72M
December 31, 1995 697.63M
December 31, 1994 588.77M
December 31, 1993 529.34M
December 31, 1992 442.49M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Eli Lilly & Co. 65.18B
Bristol Myers Squibb Co. 48.19B
RedHill Biopharma Ltd. 0.2883M
Johnson & Johnson 94.18B
Merck & Co., Inc. 64.93B